← Back to Search

Vascular Scaffold

NVS Therapy for Peripheral Vascular Disease

Phase 1
Waitlist Available
Research Sponsored by Alucent Biomedical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 - 24 (or discharge)
Awards & highlights

Study Summary

This trial is testing a new therapy to see if it is safe and effective at improving blood flow in the arteries of the leg.

Eligible Conditions
  • Peripheral Vascular Disease
  • Peripheral Arterial Disease
  • Peripheral Catheterization

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 - 24 (or discharge)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 - 24 (or discharge) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Freedom from all-cause mortality, freedom from target limb major amputation, freedom from target lesion revascularization (TLR).
NVS Drug Plasma Concentrations

Trial Design

1Treatment groups
Experimental Treatment
Group I: NVS TherapyExperimental Treatment1 Intervention
NVS Therapy will be delivered to de novo lesions in Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA) during PTA in patients with symptomatic peripheral artery disease.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NVS Therapy
2020
Completed Phase 1
~20

Find a Location

Who is running the clinical trial?

Alucent BiomedicalLead Sponsor
4 Previous Clinical Trials
133 Total Patients Enrolled
Henry HauserStudy DirectorAlucent Biomedical

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)
2020. "Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04188262.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top